Ingersoll Rand (IR) official guidance

The Company expects to collect the remainder of the recoveries in the fourth quarter.

| Free Cash Flow to Adj. Net Income conversion4 | 100%+ | •Expect to deliver 100%+ FCF conversion including the impact of ILC Dover transaction-related recoveries; excluding these recoveries, expected FCF conversion remains unchanged at ~95% •CAPEX: ~2% of sales |

| Free Cash Flow5 to Adj. Net Income conversion | ~95% | •CAPEX: ~2% of sales |

| Free Cash Flow4 to Adj. Net Income conversion | ~95% | •CAPEX: ~2% of sales |

| Free Cash Flow2 to Adj. Net Income conversion | ~95% | •CAPEX: ~2% of sales | |

| Adjusted EBITDA4 excl. Q3 IEEPA Tariff Refunds | $2,130M - $2,190M | •Corporate costs: ~$170M |

Unallocated corporate costs were $49 million in the quarter versus $34.6 million a year ago, driven largely by the incentive true-up, and we continue to expect approximately $170 million in corporate costs for the full year.

| Adjusted EBITDA5 | $2,130M - $2,190M | •Corporate costs: ~$170M •Adjusted EBITDA phasing: 1H 46% | 2H 54% |

Corporate costs are planned at $170 million and are expected to be incurred evenly per quarter throughout the remainder of the year.

| Adjusted EBITDA4 | $2,130M - $2,190M | •Corporate costs: ~$170M •Adj. EBITDA phasing: 1H 46% | 2H 54% |

Corporate costs are planned at $170 million, and they're expected to be incurred evenly per quarter throughout the year.

| Adjusted EBITDA2 | $2,130M - $2,190M | •Corporate costs: ~$170M •Adj. EBITDA phasing: 1H 46% | 2H 54% |

| Adjusted EPS4 excl. Q3 IEEPA Tariff Refunds | $3.58 to $3.70 | •Net interest expense: ~$230M •Adjusted tax rate: ~20% •Share count: ~390.5M |

| Adjusted EPS5 | $3.45 to $3.57 Expected to finish near the high end of the range | •Net interest expense: ~$230M •Adjusted tax rate: ~22% •Share count: ~391.5M •Adjusted EPS phasing: 1H 46% | 2H 54% |

We anticipate our adjusted tax rate to be roughly 23%, net interest expense to be about $230 million, and share count to be approximately 394 million.

| Adjusted EPS4 | $3.45 to $3.57 +5% growth at the midpoint | •Net interest expense: ~$230M •Adj. tax rate: ~23% •Share count: ~394M •Adj. EPS phasing: 1H 46% | 2H 54% |

We anticipate our adjusted tax rate to be approximately 23%, net interest expense to be about $230 million, and share count to be approximately 394 million.

| Adjusted EPS2 | $3.45 to $3.57 +5% growth at the midpoint | •Net interest expense: ~$230M •Adj. tax rate: ~23% •Share count: ~394M •Adj. EPS phasing: 1H 46% | 2H 54% |

| Adjusted EBITDA4 excl. Q3 IEEPA Tariff Refunds | $2,130M - $2,190M | •Corporate costs: ~$170M |

We're maintaining our adjusted EBITDA guidance range of $2.13 billion-$2.19 billion.

| Adjusted EBITDA5 | $2,130M - $2,190M | •Corporate costs: ~$170M •Adjusted EBITDA phasing: 1H 46% | 2H 54% |

Total Adjusted EBITDA for the company is expected to be in the range of $2.13-$2.19 billion.

| Adjusted EBITDA4 | $2,130M - $2,190M | •Corporate costs: ~$170M •Adj. EBITDA phasing: 1H 46% | 2H 54% |

Total Adjusted EBITDA for the company is expected to be in the range of $2.13 billion-$2.19 billion.

| Adjusted EBITDA2 | $2,130M - $2,190M | •Corporate costs: ~$170M •Adj. EBITDA phasing: 1H 46% | 2H 54% |

| Adjusted EPS4 excl. Q3 IEEPA Tariff Refunds | $3.58 to $3.70 | •Net interest expense: ~$230M •Adjusted tax rate: ~20% •Share count: ~390.5M |

| Adjusted EPS5 | $3.45 to $3.57 Expected to finish near the high end of the range | •Net interest expense: ~$230M •Adjusted tax rate: ~22% •Share count: ~391.5M •Adjusted EPS phasing: 1H 46% | 2H 54% |

We anticipate our adjusted tax rate to be roughly 23%, net interest expense to be about $230 million, and share count to be approximately 394 million.

| Adjusted EPS4 | $3.45 to $3.57 +5% growth at the midpoint | •Net interest expense: ~$230M •Adj. tax rate: ~23% •Share count: ~394M •Adj. EPS phasing: 1H 46% | 2H 54% |

We anticipate our adjusted tax rate to be approximately 23%, net interest expense to be about $230 million, and share count to be approximately 394 million.

| Adjusted EPS2 | $3.45 to $3.57 +5% growth at the midpoint | •Net interest expense: ~$230M •Adj. tax rate: ~23% •Share count: ~394M •Adj. EPS phasing: 1H 46% | 2H 54% |

| Adjusted EPS4 excl. Q3 IEEPA Tariff Refunds | $3.58 to $3.70 | •Net interest expense: ~$230M •Adjusted tax rate: ~20% •Share count: ~390.5M |

Adjusted EPS remains projected at $3.45-$3.57, and based on our current expectations, we expect results to finish near the high end of the range.

| Adjusted EPS5 | $3.45 to $3.57 Expected to finish near the high end of the range | •Net interest expense: ~$230M •Adjusted tax rate: ~22% •Share count: ~391.5M •Adjusted EPS phasing: 1H 46% | 2H 54% |

Adjusted EPS is projected to fall within the range of $3.45-$3.57, which is approximately 5% growth at the midpoint.

| Adjusted EPS4 | $3.45 to $3.57 +5% growth at the midpoint | •Net interest expense: ~$230M •Adj. tax rate: ~23% •Share count: ~394M •Adj. EPS phasing: 1H 46% | 2H 54% |

Adjusted EPS is projected to fall within the range of $3.45-$3.57, which is approximately 5% growth at the midpoint.

| Adjusted EPS2 | $3.45 to $3.57 +5% growth at the midpoint | •Net interest expense: ~$230M •Adj. tax rate: ~23% •Share count: ~394M •Adj. EPS phasing: 1H 46% | 2H 54% |

| Free Cash Flow to Adj. Net Income conversion4 | 100%+ | •Expect to deliver 100%+ FCF conversion including the impact of ILC Dover transaction-related recoveries; excluding these recoveries, expected FCF conversion remains unchanged at ~95% •CAPEX: ~2% of sales |

| Free Cash Flow5 to Adj. Net Income conversion | ~95% | •CAPEX: ~2% of sales |

Free cash flow to Adjusted Net Income conversion is expected to be approximately 95%.

| Free Cash Flow4 to Adj. Net Income conversion | ~95% | •CAPEX: ~2% of sales |

Free Cash Flow to adjusted net income conversion will be around 95%.

| Free Cash Flow2 to Adj. Net Income conversion | ~95% | •CAPEX: ~2% of sales | |

| Adjusted EPS4 excl. Q3 IEEPA Tariff Refunds | $3.58 to $3.70 | •Net interest expense: ~$230M •Adjusted tax rate: ~20% •Share count: ~390.5M |

| Adjusted EPS5 | $3.45 to $3.57 Expected to finish near the high end of the range | •Net interest expense: ~$230M •Adjusted tax rate: ~22% •Share count: ~391.5M •Adjusted EPS phasing: 1H 46% | 2H 54% |

We anticipate our adjusted tax rate to be roughly 23%, net interest expense to be about $230 million, and share count to be approximately 394 million.

| Adjusted EPS4 | $3.45 to $3.57 +5% growth at the midpoint | •Net interest expense: ~$230M •Adj. tax rate: ~23% •Share count: ~394M •Adj. EPS phasing: 1H 46% | 2H 54% |

We anticipate our adjusted tax rate to be approximately 23%, net interest expense to be about $230 million, and share count to be approximately 394 million.

| Adjusted EPS2 | $3.45 to $3.57 +5% growth at the midpoint | •Net interest expense: ~$230M •Adj. tax rate: ~23% •Share count: ~394M •Adj. EPS phasing: 1H 46% | 2H 54% |

This outlook assumes approximately 1%-3% organic growth, approximately 2.5% growth from M&A, and approximately 1% growth from FX.

Total company revenue is expected to grow between 2.5% and 4.5%, driven by organic growth of 1% at the midpoint, growth from M&A of approximately 2%, which includes the carryover impact from all transactions completed, as well as the recently announced signed transaction of Fox. Finally, we expect FX to be a tailwind of approximately 0.5%.

| Revenue Growth3 | 5.5% to 7.0% | •Currency5: ~+1% •M&A6: ~+2.5% •Organic growth4: +2% to +3.5% |

Starting with revenue, we now expect revenue growth of 4.5%-6.5%, 200 basis points higher at the midpoint, driven primarily by organic volume, reflecting a strong first half and healthy demand, particularly in the short to medium cycle side of the business.

| Revenue Growth4 | 4.5% to 6.5% | •Currency6: ~+1% •M&A7: ~+2.5% •Organic growth4: +1% to +3% •Revenue phasing: 1H 48% | 2H 52% |

Total company revenue is expected to grow between 2.5% and 4.5%, driven by organic growth of 1% at the midpoint, growth from M&A of approximately 2%, which includes the carryover impact from all transactions completed, as well as the recently announced signed transaction of Fox. Finally, we expect FX to be a tailwind of approximately 0.5%.

| Revenue Growth3 | 2.5% to 4.5% | •Currency5: ~+0.5% •M&A6: ~+2% •Organic growth4: flat to 2% •Revenue phasing: 1H 48% | 2H 52% |

Total company revenue is expected to grow between 2.5% and 4.5%, driven by organic order growth of 1% at the midpoint, 1.5% growth from M&A, which includes a carryover from all transactions completed in 2025, as well as the previously announced Scinomix acquisition, and 1% FX tailwind.

| Revenue Growth4 | 2.5% to 4.5% | •Currency5: +1% •M&A6: +1.5% •Organic growth3: flat to 2% •Revenue phasing: 1H 48% | 2H 52% |

| Revenue Growth3 | 5.5% to 7.0% | •Currency5: ~+1% •M&A6: ~+2.5% •Organic growth4: +2% to +3.5% |

This outlook assumes approximately 1%-3% organic growth, approximately 2.5% growth from M&A, and approximately 1% growth from FX.

| Revenue Growth4 | 4.5% to 6.5% | •Currency6: ~+1% •M&A7: ~+2.5% •Organic growth4: +1% to +3% •Revenue phasing: 1H 48% | 2H 52% |

Total company revenue is expected to grow between 2.5% and 4.5%, driven by organic growth of 1% at the midpoint, growth from M&A of approximately 2%, which includes the carryover impact from all transactions completed, as well as the recently announced signed transaction of Fox. Finally, we expect FX to be a tailwind of approximately 0.5%.

Total company revenue is expected to grow between 2.5% and 4.5%, driven by organic order growth of 1% at the midpoint, 1.5% growth from M&A, which includes a carryover from all transactions completed in 2025, as well as the previously announced Scinomix acquisition, and 1% FX tailwind.

| Revenue Growth4 | 2.5% to 4.5% | •Currency5: +1% •M&A6: +1.5% •Organic growth3: flat to 2% •Revenue phasing: 1H 48% | 2H 52% |

This outlook assumes approximately 1%-3% organic growth, approximately 2.5% growth from M&A, and approximately 1% growth from FX.

| Revenue Growth4 | 4.5% to 6.5% | •Currency6: ~+1% •M&A7: ~+2.5% •Organic growth4: +1% to +3% •Revenue phasing: 1H 48% | 2H 52% |

Total company revenue is expected to grow between 2.5% and 4.5%, driven by organic growth of 1% at the midpoint, growth from M&A of approximately 2%, which includes the carryover impact from all transactions completed, as well as the recently announced signed transaction of Fox. Finally, we expect FX to be a tailwind of approximately 0.5%.

Total company revenue is expected to grow between 2.5% and 4.5%, driven by organic order growth of 1% at the midpoint, 1.5% growth from M&A, which includes a carryover from all transactions completed in 2025, as well as the previously announced Scinomix acquisition, and 1% FX tailwind.

| Revenue Growth4 | 2.5% to 4.5% | •Currency5: +1% •M&A6: +1.5% •Organic growth3: flat to 2% •Revenue phasing: 1H 48% | 2H 52% |

| Revenue Growth4 | 4.5% to 6.5% | •Currency6: ~+1% •M&A7: ~+2.5% •Organic growth4: +1% to +3% •Revenue phasing: 1H 48% | 2H 52% |

| Revenue Growth3 | 2.5% to 4.5% | •Currency5: ~+0.5% •M&A6: ~+2% •Organic growth4: flat to 2% •Revenue phasing: 1H 48% | 2H 52% |

| Revenue Growth4 | 2.5% to 4.5% | •Currency5: +1% •M&A6: +1.5% •Organic growth3: flat to 2% •Revenue phasing: 1H 48% | 2H 52% |

| Adjusted EBITDA5 | $2,130M - $2,190M | •Corporate costs: ~$170M •Adjusted EBITDA phasing: 1H 46% | 2H 54% |

| Adjusted EBITDA4 | $2,130M - $2,190M | •Corporate costs: ~$170M •Adj. EBITDA phasing: 1H 46% | 2H 54% |

| Adjusted EBITDA2 | $2,130M - $2,190M | •Corporate costs: ~$170M •Adj. EBITDA phasing: 1H 46% | 2H 54% |